Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Daan W. Huntjens"'
Autor:
Elles J. Reimerink, Daan W. Huntjens, Lindsey G. Pelkmans, Jan-Willem H. J. Geerts, Eric J. F. Franssen
Publikováno v:
Toxics, Vol 11, Iss 2, p 196 (2023)
Here we describe the case of a potentially lethal caffeine intoxication after the reported ingestion of 10 g of caffeine. Due to hemodynamic instability with tachycardia and hypertension with an insufficient effect of continuous labetalol infusion, t
Externí odkaz:
https://doaj.org/article/46e61cbdac8f402ba71b71be293abf85
Autor:
Daan W. Huntjens, Jacob A. Dijkstra, Lisanne N. Verwiel, Mirjam Slijkhuis, Paul Elbers, Matthijs R. A. Welkers, Agnes I. Veldkamp, Marianne A. Kuijvenhoven, David C. de Leeuw, Heshu Abdullah-Koolmees, Maria T. Kuipers, Imke H. Bartelink
Publikováno v:
Pharmaceutics, Vol 15, Iss 1, p 163 (2023)
Herpes simplex virus (HSV) and cytomegalovirus (CMV) are DNA viruses that are common among humans. Severely immunocompromised patients are at increased risk of developing HSV or CMV disease due to a weakened immune system. Antiviral therapy can be ch
Externí odkaz:
https://doaj.org/article/d1ac61ace17745d398d81e6bbaf036e9
Autor:
Forike K. Martens, Daan W. Huntjens, Tessel Rigter, Meike Bartels, Pierre M. Bet, Martina C. Cornel
Publikováno v:
Frontiers in Pharmacology, Vol 10 (2020)
IntroductionThe fluoropyrimidines (FP) (5-Fluorouracil, capecitabine, and tegafur) are commonly used anti-cancer drugs, but lead to moderate to severe toxicity in about 10–40% of patients. DPD testing [either the enzyme activity of dihydropyrimidin
Externí odkaz:
https://doaj.org/article/954d40ebde3747c0a1475b19c50197ff
Autor:
Darko Mitrovic, Daan W. Huntjens, Elisabeth A. J. de Vos, Martijn van Tellingen, Eric J. F. Franssen
Publikováno v:
Journal of clinical pharmacy and therapeuticsREFERENCES. 47(9)
Many severe intoxications occur with substances with no specific antidote, which is why methods of extracorporeal elimination represent a particularly useful and even critical component in their management. The purpose of this review is to summarize
Autor:
Forike K. Martens, Daan W. Huntjens, Tessel Rigter, Meike Bartels, Pierre M. Bet, Martina C. Cornel
Publikováno v:
Martens, F K, Huntjens, D W, Rigter, T, Bartels, M, Bet, P M & Cornel, M C 2020, ' DPD testing before treatment with fluoropyrimidines in the Amsterdam UMCs : An evaluation of current pharmacogenetic practice ', Frontiers in Pharmacology, vol. 10, 1609 . https://doi.org/10.3389/fphar.2019.01609, https://doi.org/10.3389/fphar.2019.01609
Frontiers in Pharmacology
Frontiers in Pharmacology, 10:1609. Frontiers Media S.A.
Martens, F K, Huntjens, D W, Rigter, T, Bartels, M, Bet, P M & Cornel, M C 2020, ' DPD testing before treatment with fluoropyrimidines in the Amsterdam UMCs : An evaluation of current pharmacogenetic practice ', Frontiers in Pharmacology, vol. 10, no. January, 1609, pp. 1-10 . https://doi.org/10.3389/fphar.2019.01609
Frontiers in Pharmacology, 10(January):1609, 1-10. Frontiers Media S.A.
Frontiers in Pharmacology, Vol 10 (2020)
Frontiers in Pharmacology
Frontiers in Pharmacology, 10:1609. Frontiers Media S.A.
Martens, F K, Huntjens, D W, Rigter, T, Bartels, M, Bet, P M & Cornel, M C 2020, ' DPD testing before treatment with fluoropyrimidines in the Amsterdam UMCs : An evaluation of current pharmacogenetic practice ', Frontiers in Pharmacology, vol. 10, no. January, 1609, pp. 1-10 . https://doi.org/10.3389/fphar.2019.01609
Frontiers in Pharmacology, 10(January):1609, 1-10. Frontiers Media S.A.
Frontiers in Pharmacology, Vol 10 (2020)
Introduction: The fluoropyrimidines (FP) (5-Fluorouracil, capecitabine, and tegafur) are commonly used anti-cancer drugs, but lead to moderate to severe toxicity in about 10-40% of patients. DPD testing [either the enzyme activity of dihydropyrimidin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32b8c06ce45113ae846d553447ea8f02
https://research.vumc.nl/en/publications/c8276509-256a-4f44-bb86-13f3f036171b
https://research.vumc.nl/en/publications/c8276509-256a-4f44-bb86-13f3f036171b